3,5-Di-O-caffeoylquinicacidmethylester exhibits potent inhibitory activities against the formation of advanced glycation end products (AGEs); it exhibits cytotoxicity actions against human cervix carcinoma HeLa cells. 3,5-Di-O-caffeoylquinicacidmethylester shows high efficiency and low toxicity with antivirus activity against RSV.